Michelle Chung '14 of Acton, MA has been selected by the Siemens Foundation as a semi-finalist in the Math, Science, & Technology Competition. As one of the nation's premier research competitions for high school students, there were nearly 1,600 submissions and 331 semi-finalists, 12 of whom hail from Massachusetts. "These incredible students have invested significant time and energy to advance research and exploration in critical fields," said David Etzwiler, CEO of the Siemens Foundation. Michelle's research tested whether metformin, an insulin-sensitizing anti-diabetic agent, may be a potential therapeutic modality of non-alcoholic fatty liver disease (NAFLD), the most common form of chronic liver disease. Michelle tested whether metformin enhances hepatic lipid metabolism by treating mice for 12 weeks.
Congratulations to Michelle! Her research has also been submitted to the Intel Science Talent Search, the results of which will be announced in early 2014.